CCM
JAZZ icon

Condor Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Condor Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,617
Closed -$1.75M – 280
2020
Q4 		$1.75M Sell
10,617
-31
-0.3% -$4.62K 0.22% 101
2020
Q3 		$1.52M Sell
10,648
-408
-4% -$50.6K 0.22% 105
2020
Q2 		$1.22M Sell
11,056
-28
-0.3% -$3.1K 0.19% 113
2020
Q1 		$1.11M Buy
11,084
+501
+5% +$64.8K 0.2% 100
2019
Q4 		$1.58M Buy
10,583
+169
+2% +$23K 0.23% 102
2019
Q3 		$1.33M Buy
10,414
+318
+3% +$42.6K 0.21% 112
2019
Q2 		$1.44M Buy
10,096
+420
+4% +$56.4K 0.22% 106
2019
Q1 		$1.38M Buy
9,676
+36
+0.4% +$4.7K 0.23% 106
2018
Q4 		$1.2M Buy
9,640
+302
+3% +$44.8K 0.22% 106
2018
Q3 		$1.57M Buy
9,338
+141
+2% +$24.2K 0.29% 90
2018
Q2 		$1.58M Buy
9,197
+91
+1% +$14.9K 0.3% 87
2018
Q1 		$1.38M Buy
9,106
+91
+1% +$13.3K 0.3% 94
2017
Q4 		$1.21M Buy
9,015
+237
+3% +$32.9K 0.25% 103
2017
Q3 		$1.28M Buy
8,778
+280
+3% +$42.3K 0.26% 93
2017
Q2 		$1.32M Sell
8,498
-34
-0.4% -$5.2K 0.28% 91
2017
Q1 		$1.24M Buy
8,532
+4,289
+101% +$559K 0.27% 91
2016
Q4 		$463K Sell
4,243
-4,700
-53% -$524K 0.1% 145
2016
Q3 		$1.09M Buy
8,943
+68
+0.8% +$9.17K 0.25% 96
2016
Q2 		$1.25M Buy
8,875
+202
+2% +$29.8K 0.3% 83
2016
Q1 		$1.13M Buy
8,673
+946
+12% +$118K 0.27% 92
2015
Q4 		$1.09M Buy
7,727
+173
+2% +$24K 0.27% 93
2015
Q3 		$1M Buy
7,554
+268
+4% +$46.1K 0.26% 99
2015
Q2 		$1.28M Buy
7,286
+281
+4% +$50.5K 0.31% 89
2015
Q1 		$1.21M Buy
+7,005
New +$1.2M 0.29% 96

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Condor Capital Management's JAZZ Position: Q1 2021 in Review

Condor Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2021, closing a stake of 10,617 shares — an estimated $1.75M sold.

Condor Capital Management first reported a position in JAZZ in Q1 2015 and held it in 24 quarters. The position peaked at $1.75M in Q4 2020. 442 funds tracked by Wall St. Rank hold JAZZ as of Q1 2021.

  • Condor Capital Management reported no remaining Jazz Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Condor Capital Management sold 10,617 Jazz Pharmaceuticals shares in Q1 2021, an estimated $1.75M.
  • Condor Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 24 quarters.
  • Condor Capital Management's Jazz Pharmaceuticals position peaked at $1.75M in Q4 2020.
  • 442 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2021.

Based on Condor Capital Management's 13F filing for Q1 2021, filed 10 May 2021.